The treatment of functional dyspepsia: present and future.


Journal

Expert review of gastroenterology & hepatology
ISSN: 1747-4132
Titre abrégé: Expert Rev Gastroenterol Hepatol
Pays: England
ID NLM: 101278199

Informations de publication

Date de publication:
Jan 2023
Historique:
pubmed: 3 1 2023
medline: 11 1 2023
entrez: 2 1 2023
Statut: ppublish

Résumé

Functional dyspepsia (FD) is a prevalent, but frequently overlooked and/or under diagnosed disorder of gut-brain interaction (DGBI). Functional dyspepsia frequently co-exists with other DGBIs, and persistent symptoms have a significant impact on patients' quality of life. A variety of therapies (e.g. diet, probiotics, antibiotics, acid suppressants, neuromodulators, prokinetics) are employed to treat the multiple symptoms of FD, although none are uniformly effective. This review covers currently available therapies for the treatment of FD in addition to novel and emerging therapies that may change the treatment paradigm in the near future. PubMed, Embase and the Cochrane data bank were searched from 1990 to October 2022 for relevant articles. Dietary intervention, eradication of

Identifiants

pubmed: 36588474
doi: 10.1080/17474124.2023.2162877
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-20

Auteurs

Brian E Lacy (BE)

Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.

R Christopher Chase (RC)

Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.

David J Cangemi (DJ)

Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH